Latest news
USFDA Approves Takeda's Orzeyful for Rare Narcolepsy Type 1 Sleep Disorder - Medical DialoguesMedical Dialogues · Sat, 08 Aug 2026 14:47:07 GMTDabur Faces USFDA Warning Letter Over Falsified Records, CGMP Violations at Silvassa Facility - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 17:05:11 GMTRelief for Dabur India: Delhi HC Stays FSSAI Ban on Products Carrying '100%' Claims - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 14:45:39 GMTUSFDA Issues Warning Letter To Dabur Over Data Integrity, Manufacturing Lapses At Silvassa Plant - Free Press JournalFree Press Journal · Thu, 06 Aug 2026 05:55:49 GMTDabur India Promotes Binit Kumar as Head of Marketing for Health Supplements, Baby Care - Medical DialoguesMedical Dialogues · Fri, 31 Jul 2026 07:00:00 GMTDr Reddy’s Profit Slumps 69%, Srikakulam Unit Faces USFDA Audit - WhalesbookWhalesbook · Wed, 29 Jul 2026 19:26:54 GMT